Pliant Therapeutics, Inc. (PLRX) Free Cash Flow

Pliant Therapeutics, Inc. (PLRX) free cash flow history and trends. Track FCF in Excel with MarketXLS.

Free Cash Flow Data

PeriodFree Cash Flow (USD)
2020-12-31-$38.80M
2021-12-31-$77.40M
2022-12-31-$96.39M
2023-12-31-$117.28M
2024-12-31-$159.35M
2025-12-31-$128.71M

How PLRX compares with sector peers

SymbolCompanyFree cash flow (latest fiscal year)
OSUROraSure Technologies Inc.-$53.22M
VTGNVistagen Therapeutics Inc.-$66.44M
LXRXLexicon Pharmaceuticals Inc.-$67.85M
ABEOAbeona Therapeutics Inc.-$84.30M
INOInovio Pharmaceuticals Inc.-$88.92M

These are five companies in the same sector as PLRX with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.

Get Pliant Therapeutics, Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Free_Cash_Flow("PLRX", 2024)

BUY NOW